id | C00020218 |
---|---|
Name | 7-Hydroxyflavone |
CAS RN | 6665-86-7 |
Standard InChI | InChI=1S/C15H10O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-9,16H |
Standard InChI (Main Layer) | InChI=1S/C15H10O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-9,16H |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 76 |
By standard InChI | CHEMBL276915 |
---|---|
By standard InChI Main Layer | CHEMBL276915 |
By LinkDB | C11264 |
---|
By CAS RN | C429845 |
---|
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Acacia aroma | 207708 | Fabaceae | rosids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | CHEMBL276915 |
CHEMBL957998
(1)
CHEMBL957999
(1)
|
0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL276915 |
CHEMBL636747
(1)
CHEMBL643650
(1)
|
0 / 0 |
P62158 | Calmodulin | Unclassified protein | CHEMBL276915 |
CHEMBL1647727
(2)
CHEMBL1647728
(1)
|
1 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL276915 |
CHEMBL1023248
(1)
|
1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL276915 |
CHEMBL2019838
(1)
CHEMBL2019839
(1)
|
1 / 2 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | CHEMBL276915 |
CHEMBL641142
(1)
|
1 / 1 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL276915 |
CHEMBL926333
(1)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL276915 |
CHEMBL1827948
(1)
|
1 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL276915 |
CHEMBL1014691
(1)
|
0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL276915 |
CHEMBL924097
(1)
|
0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | CHEMBL276915 |
CHEMBL2019842
(1)
CHEMBL2019843
(1)
|
1 / 2 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL276915 |
CHEMBL2114807
(1)
|
4 / 2 |
P00915 | Carbonic anhydrase 1 | Lyase | CHEMBL276915 |
CHEMBL2019836
(1)
CHEMBL2019837
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL276915 |
CHEMBL1052488
(1)
CHEMBL1052489
(1)
|
0 / 1 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | CHEMBL276915 |
CHEMBL1105634
(1)
|
2 / 2 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | CHEMBL276915 |
CHEMBL924094
(1)
|
2 / 0 |
P37058 | Testosterone 17-beta-dehydrogenase 3 | Enzyme | CHEMBL276915 |
CHEMBL870480
(1)
CHEMBL870482
(1)
|
1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL276915 |
CHEMBL1261121
(1)
|
0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | CHEMBL276915 |
CHEMBL2019840
(1)
CHEMBL2019841
(1)
|
0 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL276915 |
CHEMBL924095
(1)
|
0 / 0 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | CHEMBL276915 |
CHEMBL958788
(1)
CHEMBL958789
(1)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL276915 |
CHEMBL1052486
(1)
|
3 / 4 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL276915 |
CHEMBL941407
(1)
|
0 / 1 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | CHEMBL276915 |
CHEMBL731145
(1)
|
0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL276915 |
CHEMBL731145
(1)
|
1 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C429845 | 1645 |
AKR1C1
2-ALPHA-HSD 20-ALPHA-HSD C9 DD1 DD1/DD2 DDH DDH1 H-37 HAKRC HBAB MBAB |
aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) | 7-hydroxyflavone binds to and results in decreased activity of AKR1C1 protein |
affects binding
/ decreases activity |
protein |
16962702
|
C429845 | 8644 |
AKR1C3
DD3 DDX HA1753 HAKRB HAKRe HSD17B5 PGFS hluPGFS |
aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | 7-hydroxyflavone results in decreased activity of AKR1C3 protein |
decreases activity
|
protein |
19007764
|
C429845 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | 7-hydroxyflavone results in decreased activity of CYP19A1 protein |
decreases activity
|
protein |
15319488
|
C429845 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | 7-hydroxyflavone results in decreased activity of CYP1A1 protein |
decreases activity
|
protein |
21053930
|
C429845 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 7-hydroxyflavone results in decreased activity of CYP1A2 protein |
decreases activity
|
protein |
21053930
|
C429845 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | 7-hydroxyflavone binds to and results in decreased activity of CYP1B1 protein |
affects binding
/ decreases activity |
protein |
21053930
|
C429845 | 1559 |
CYP2C9
CPC9 CYP2C CYP2C10 CYPIIC9 P450IIC9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | 7-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] |
decreases reaction
/ increases hydroxylation |
protein |
21053930
|
C429845 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | 7-hydroxyflavone results in decreased activity of CYP3A4 protein |
decreases activity
|
protein |
21053930
|
C429845 | 6513 |
SLC2A1
DYT17 DYT18 DYT9 EIG12 GLUT GLUT1 GLUT1DS HTLVR PED |
solute carrier family 2 (facilitated glucose transporter), member 1 | 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] |
affects transport
/ decreases reaction |
protein |
14642735
|
C429845 | 6513 |
SLC2A1
DYT17 DYT18 DYT9 EIG12 GLUT GLUT1 GLUT1DS HTLVR PED |
solute carrier family 2 (facilitated glucose transporter), member 1 | 7-hydroxyflavone results in decreased activity of SLC2A1 protein |
decreases activity
|
protein |
14642735
|
C429845 | 7366 |
UGT2B15
HLUG4 UDPGT_2B8 UDPGT2B15 UDPGTH3 UGT2B8 |
UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) | UGT2B15 protein results in increased metabolism of 7-hydroxyflavone |
increases metabolic processing
|
protein |
7835232
|
OMIM | preferred title | UniProt |
---|---|---|
#264300 | 17-beta hydroxysteroid dehydrogenase iii deficiency |
P37058
|
#610251 | Alcohol sensitivity, acute |
P05091
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#114500 | Colorectal cancer; crc |
P18054
|
#133239 | Esophageal cancer |
P18054
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#614916 | Ventricular tachycardia, catecholaminergic polymorphic, 4; cpvt4 |
P62158
|
#278300 | Xanthinuria, type i |
P47989
|
KEGG | disease name | UniProt |
---|---|---|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
P37058 (related) |
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00027 | Ovarian cancer |
P38398
(related)
|
H00031 | Breast cancer |
P38398
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|